HHL-U:CA:TSX-Harvest Healthcare Leaders Income ETF (USD)

ETF | Others |

Last Closing

CAD 7.98

Change

+0.11 (+1.40)%

Market Cap

N/A

Volume

474.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

+0.45 (+1.42%)

CAD 6.91B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.02%)

CAD 6.63B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.07 (+0.25%)

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

-0.70 (-2.72%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.62 (+1.86%)

CAD 4.54B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 4.20B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.82 (+1.79%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.68 (-2.27%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.38 (+3.49%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

N/A

CAD 2.78B

ETFs Containing HHL-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.44% 54% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.44% 53% F 49% F
Trailing 12 Months  
Capital Gain -7.75% 11% F 19% F
Dividend Return 2.72% 68% D+ 49% F
Total Return -5.03% 11% F 20% F
Trailing 5 Years  
Capital Gain 2.05% 31% F 32% F
Dividend Return 38.79% 89% A- 81% B-
Total Return 40.84% 45% F 40% F
Average Annual (5 Year Horizon)  
Capital Gain 2.87% 47% F 43% F
Dividend Return 3.77% 49% F 40% F
Total Return 0.90% 78% C+ 35% F
Risk Return Profile  
Volatility (Standard Deviation) 7.01% 69% C- 84% B
Risk Adjusted Return 53.76% 60% D- 63% D
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.